Skip to content

Clinical trials

Mental Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: China Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20142
20162
20172
20183
20191
20214
20222
20236
20244
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting9
Unknown status9
Not yet recruiting5
Enrolling by invitation2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Mental Health Center7
AstraZeneca2
Fujian Provincial Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Wuhan University2
Beijing HuiLongGuan Hospital1
Central South University1
ChunBao Li1
Cui Yimin1
Deng Dongrui1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders38
Alzheimer Disease6
Nervous System Diseases6
Neurodegenerative Diseases6
Bipolar Disorder5
Brain Diseases5
Central Nervous System Diseases5
Dementia5
Schizophrenia5
Cognitive Dysfunction4

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.